1-8355558-G-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001042681.2(RERE):c.4528C>A(p.Pro1510Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00123 in 1,604,514 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P1510L) has been classified as Uncertain significance.
Frequency
Consequence
NM_001042681.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RERE | NM_001042681.2 | c.4528C>A | p.Pro1510Thr | missense_variant | 22/23 | ENST00000400908.7 | NP_001036146.1 | |
RERE | NM_012102.4 | c.4528C>A | p.Pro1510Thr | missense_variant | 23/24 | NP_036234.3 | ||
RERE | NM_001042682.2 | c.2866C>A | p.Pro956Thr | missense_variant | 12/13 | NP_001036147.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RERE | ENST00000400908.7 | c.4528C>A | p.Pro1510Thr | missense_variant | 22/23 | 1 | NM_001042681.2 | ENSP00000383700.2 |
Frequencies
GnomAD3 genomes AF: 0.00505 AC: 768AN: 152206Hom.: 4 Cov.: 32
GnomAD3 exomes AF: 0.00164 AC: 383AN: 234062Hom.: 2 AF XY: 0.00127 AC XY: 163AN XY: 128358
GnomAD4 exome AF: 0.000826 AC: 1199AN: 1452190Hom.: 2 Cov.: 32 AF XY: 0.000770 AC XY: 555AN XY: 721154
GnomAD4 genome AF: 0.00504 AC: 768AN: 152324Hom.: 4 Cov.: 32 AF XY: 0.00486 AC XY: 362AN XY: 74492
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 02, 2024 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
RERE-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 29, 2022 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Neurodevelopmental disorder with or without anomalies of the brain, eye, or heart Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Nov 12, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at